Loading...

Yoshikazu Takada

Title(s)Professor, Dermatology
SchoolUniversity of California, Davis
Phone916-734-7443
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Takada YK, Yu J, Shimoda M, Takada Y. Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling. J Immunol. 2019 Jul 22. PMID: 31331973.
      View in: PubMed
    2. Zhu K, Takada Y, Nakajima K, Sun Y, Jiang J, Zhang Y, Zeng Q, Takada Y, Zhao M. Expression of integrins to control migration direction of electrotaxis. FASEB J. 2019 May 22; fj201802657R. PMID: 31116572.
      View in: PubMed
    3. Rajan A, Persson BD, Frängsmyr L, Olofsson A, Sandblad L, Heino J, Takada Y, Mould AP, Schnapp LM, Gall J, Arnberg N. Enteric Species F Human Adenoviruses use Laminin-Binding Integrins as Co-Receptors for Infection of Ht-29 Cells. Sci Rep. 2018 07 03; 8(1):10019. PMID: 29968781.
      View in: PubMed
    4. Fujita M, Davari P, Takada YK, Takada Y. Stromal cell-derived factor-1 (CXCL12) activates integrins by direct binding to an allosteric ligand-binding site (site 2) of integrins without CXCR4. Biochem J. 2018 02 16; 475(4):723-732. PMID: 29301984.
      View in: PubMed
    5. Takada YK, Yu J, Fujita M, Saegusa J, Wu CY, Takada Y. Direct binding to integrins and loss of disulfide linkage in interleukin-1ß (IL-1ß) are involved in the agonistic action of IL-1ß. J Biol Chem. 2017 12 08; 292(49):20067-20075. PMID: 29030430.
      View in: PubMed
    6. Cedano Prieto DM, Cheng Y, Chang CC, Yu J, Takada YK, Takada Y. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. PLoS One. 2017; 12(9):e0184285. PMID: 28873464.
      View in: PubMed
    7. Mori S, Hatori N, Kawaguchi N, Hamada Y, Shih TC, Wu CY, Lam KS, Matsuura N, Yamamoto H, Takada YK, Takada Y. The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis. Biosci Rep. 2017 04 28; 37(2). PMID: 28302677.
      View in: PubMed
    8. Takada Y, Takada YK, Fujita M. Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1. Cytokine Growth Factor Rev. 2017 Apr; 34:67-72. PMID: 28190785.
      View in: PubMed
    9. Takada Y, Fujita M. Secreted Phospholipase A2 Type IIA (sPLA2-IIA) Activates Integrins in an Allosteric Manner. Adv Exp Med Biol. 2017; 925:103-115. PMID: 27864802.
      View in: PubMed
    10. Yu J, Lee CY, Changou CA, Cedano-Prieto DM, Takada YK, Takada Y. The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin avß3. Biochem J. 2017 02 15; 474(4):589-596. PMID: 27993971.
      View in: PubMed
    11. Mould AP, Askari JA, Byron A, Takada Y, Jowitt TA, Humphries MJ. Ligand-induced Epitope Masking: DISSOCIATION OF INTEGRIN a5ß1-FIBRONECTIN COMPLEXES ONLY BY MONOCLONAL ANTIBODIES WITH AN ALLOSTERIC MODE OF ACTION. J Biol Chem. 2016 Sep 30; 291(40):20993-21007. PMID: 27484800.
      View in: PubMed
    12. Wang Y, Xiao W, Zhang Y, Meza L, Tseng H, Takada Y, Ames JB, Lam KS. Optimization of RGD-Containing Cyclic Peptides against avß3 Integrin. Mol Cancer Ther. 2016 Feb; 15(2):232-40. PMID: 26719578.
      View in: PubMed
    13. Mori S, Kodaira M, Ito A, Okazaki M, Kawaguchi N, Hamada Y, Takada Y, Matsuura N. Enhanced Expression of Integrin avß3 Induced by TGF-ß Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-ß-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells. PLoS One. 2015; 10(9):e0137486. PMID: 26334633.
      View in: PubMed
    14. Civra A, Giuffrida MG, Donalisio M, Napolitano L, Takada Y, Coulson BS, Conti A, Lembo D. Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition. J Biol Chem. 2015 May 08; 290(19):12403-14. PMID: 25814665.
      View in: PubMed
    15. Fujita M, Zhu K, Fujita CK, Zhao M, Lam KS, Kurth MJ, Takada YK, Takada Y. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins avß3, a4ß1, and a5ß1. J Biol Chem. 2015 Jan 02; 290(1):259-71. PMID: 25398877.
      View in: PubMed
    16. Fujita M, Takada YK, Takada Y. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site. PLoS One. 2014; 9(5):e96372. PMID: 24789099.
      View in: PubMed
    17. Fujita M, Takada YK, Izumiya Y, Takada Y. The binding of monomeric C-reactive protein (mCRP) to Integrins avß3 and a4ß1 is related to its pro-inflammatory action. PLoS One. 2014; 9(4):e93738. PMID: 24695572.
      View in: PubMed
    18. Fujita M, Ieguchi K, Cedano-Prieto DM, Fong A, Wilkerson C, Chen JQ, Wu M, Lo SH, Cheung AT, Wilson MD, Cardiff RD, Borowsky AD, Takada YK, Takada Y. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R. J Biol Chem. 2013 Jul 05; 288(27):19593-603. PMID: 23696648.
      View in: PubMed
    19. Mori S, Tran V, Nishikawa K, Kaneda T, Hamada Y, Kawaguchi N, Fujita M, Saegusa J, Takada YK, Matsuura N, Zhao M, Takada Y. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis. PLoS One. 2013; 8(2):e57927. PMID: 23469107.
      View in: PubMed
    20. Fujita M, Takada YK, Takada Y. Insulin-like growth factor (IGF) signaling requires avß3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation. J Biol Chem. 2013 Feb 01; 288(5):3059-69. PMID: 23243309.
      View in: PubMed
    21. Fujita M, Takada YK, Takada Y. Integrins avß3 and a4ß1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1. J Immunol. 2012 Dec 15; 189(12):5809-19. PMID: 23125415.
      View in: PubMed
    22. Ye L, Dickerson T, Kaur H, Takada YK, Fujita M, Liu R, Knapp JM, Lam KS, Schore NE, Kurth MJ, Takada Y. Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin avß3. Bioorg Med Chem Lett. 2013 Jan 01; 23(1):340-5. PMID: 23164706.
      View in: PubMed
    23. Takada Y. Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis). J Biomed Biotechnol. 2012; 2012:136302. PMID: 23125522.
      View in: PubMed
    24. Uematsu T, Konishi C, Hoshino D, Han X, Tomari T, Egawa N, Takada Y, Isobe T, Seiki M, Koshikawa N. Identification of proteins that associate with integrin a2 by proteomic analysis in human fibrosarcoma HT-1080 cells. J Cell Physiol. 2012 Aug; 227(8):3072-9. PMID: 21989839.
      View in: PubMed
    25. Fujita M, Ieguchi K, Davari P, Yamaji S, Taniguchi Y, Sekiguchi K, Takada YK, Takada Y. Cross-talk between integrin a6ß4 and insulin-like growth factor-1 receptor (IGF1R) through direct a6ß4 binding to IGF1 and subsequent a6ß4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions. J Biol Chem. 2012 Apr 06; 287(15):12491-500. PMID: 22351760.
      View in: PubMed
    26. Jiang JX, Chen X, Hsu DK, Baghy K, Serizawa N, Scott F, Takada Y, Takada Y, Fukada H, Chen J, Devaraj S, Adamson R, Liu FT, Török NJ. Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15; 302(4):G439-46. PMID: 22159281.
      View in: PubMed
    27. Shih YP, Takada Y, Lo SH. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells. Mol Cancer Res. 2012 Jan; 10(1):34-9. PMID: 22064653.
      View in: PubMed
    28. Haudenschild DR, Hong E, Yik JH, Chromy B, Mörgelin M, Snow KD, Acharya C, Takada Y, Di Cesare PE. Enhanced activity of transforming growth factor ß1 (TGF-ß1) bound to cartilage oligomeric matrix protein. J Biol Chem. 2011 Dec 16; 286(50):43250-8. PMID: 21940632.
      View in: PubMed
    29. Fleming FE, Graham KL, Takada Y, Coulson BS. Determinants of the specificity of rotavirus interactions with the alpha2beta1 integrin. J Biol Chem. 2011 Feb 25; 286(8):6165-74. PMID: 21138834.
      View in: PubMed
    30. Xiao W, Wang Y, Lau EY, Luo J, Yao N, Shi C, Meza L, Tseng H, Maeda Y, Kumaresan P, Liu R, Lightstone FC, Takada Y, Lam KS. The use of one-bead one-compound combinatorial library technology to discover high-affinity avß3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Ther. 2010 Oct; 9(10):2714-23. PMID: 20858725.
      View in: PubMed
    31. Ieguchi K, Fujita M, Ma Z, Davari P, Taniguchi Y, Sekiguchi K, Wang B, Takada YK, Takada Y. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling. J Biol Chem. 2010 Oct 08; 285(41):31388-98. PMID: 20682778.
      View in: PubMed
    32. Yamaji S, Saegusa J, Ieguchi K, Fujita M, Mori S, Takada YK, Takada Y. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist. PLoS One. 2010 Apr 21; 5(4):e10273. PMID: 20422052.
      View in: PubMed
    33. Takada Y, Ono Y, Saegusa J, Sagusa J, Mitsiades C, Mitsiades N, Tsai J, He Y, Maningding E, Coleman A, Ramirez-Maverakis D, Rodrigues R, Rodriquez R, Takada Y, Maverakis E. A T cell-binding fragment of fibrinogen can prevent autoimmunity. J Autoimmun. 2010 Jun; 34(4):453-9. PMID: 20036106.
      View in: PubMed
    34. Saegusa J, Yamaji S, Ieguchi K, Wu CY, Lam KS, Liu FT, Takada YK, Takada Y. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling. J Biol Chem. 2009 Sep 04; 284(36):24106-14. PMID: 19578119.
      View in: PubMed
    35. Yao N, Xiao W, Wang X, Marik J, Park SH, Takada Y, Lam KS. Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J Med Chem. 2009 Jan 08; 52(1):126-33. PMID: 19055415.
      View in: PubMed
    36. Guo M, Daines D, Tang J, Shen Q, Perrin RM, Takada Y, Yuan SY, Wu MH. Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism. Arterioscler Thromb Vasc Biol. 2009 Mar; 29(3):394-400. PMID: 19122172.
      View in: PubMed
    37. Saegusa J, Akakura N, Wu CY, Hoogland C, Ma Z, Lam KS, Liu FT, Takada YK, Takada Y. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem. 2008 Sep 19; 283(38):26107-15. PMID: 18635536.
      View in: PubMed
    38. Mori S, Wu CY, Yamaji S, Saegusa J, Shi B, Ma Z, Kuwabara Y, Lam KS, Isseroff RR, Takada YK, Takada Y. Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling. J Biol Chem. 2008 Jun 27; 283(26):18066-75. PMID: 18441324.
      View in: PubMed
    39. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-Habermann B, Takada Y, Mueller BM, Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood. 2008 Jan 01; 111(1):190-9. PMID: 17901245.
      View in: PubMed
    40. Fleming FE, Graham KL, Taniguchi K, Takada Y, Coulson BS. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1. Arch Virol. 2007; 152(6):1087-101. PMID: 17318737.
      View in: PubMed
    41. Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007; 8(5):215. PMID: 17543136.
      View in: PubMed
    42. Akakura N, Hoogland C, Takada YK, Saegusa J, Ye X, Liu FT, Cheung AT, Takada Y. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth. Cancer Res. 2006 Oct 01; 66(19):9691-7. PMID: 17018627.
      View in: PubMed
    43. Peng L, Liu R, Marik J, Wang X, Takada Y, Lam KS. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol. 2006 Jul; 2(7):381-9. PMID: 16767086.
      View in: PubMed
    44. Graham KL, Takada Y, Coulson BS. Rotavirus spike protein VP5* binds alpha2beta1 integrin on the cell surface and competes with virus for cell binding and infectivity. J Gen Virol. 2006 May; 87(Pt 5):1275-83. PMID: 16603530.
      View in: PubMed
    45. Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, Takada Y. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Thromb Haemost. 2006 Mar; 95(3):524-34. PMID: 16525582.
      View in: PubMed
    46. Wu PL, Lee SC, Chuang CC, Mori S, Akakura N, Wu WG, Takada Y. Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family. J Biol Chem. 2006 Mar 24; 281(12):7937-45. PMID: 16407244.
      View in: PubMed
    47. Graham KL, Fleming FE, Halasz P, Hewish MJ, Nagesha HS, Holmes IH, Takada Y, Coulson BS. Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands. J Gen Virol. 2005 Dec; 86(Pt 12):3397-408. PMID: 16298987.
      View in: PubMed
    48. Thodeti CK, Fröhlich C, Nielsen CK, Takada Y, Fässler R, Albrechtsen R, Wewer UM. ADAM12-mediated focal adhesion formation is differently regulated by beta1 and beta3 integrins. FEBS Lett. 2005 Oct 24; 579(25):5589-95. PMID: 16213489.
      View in: PubMed
    49. Graham KL, Zeng W, Takada Y, Jackson DC, Coulson BS. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol. 2004 Nov; 78(21):11786-97. PMID: 15479820.
      View in: PubMed
    50. Muramatsu H, Zou P, Suzuki H, Oda Y, Chen GY, Sakaguchi N, Sakuma S, Maeda N, Noda M, Takada Y, Muramatsu T. alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor. J Cell Sci. 2004 Oct 15; 117(Pt 22):5405-15. PMID: 15466886.
      View in: PubMed
    51. Mikawa M, Wang H, Guo L, Liu R, Marik J, Takada Y, Lam K, Lau D. Novel peptide ligands for integrin alpha 4 beta 1 overexpressed in cancer cells. Mol Cancer Ther. 2004 Oct; 3(10):1329-34. PMID: 15486200.
      View in: PubMed
    52. Schwarz M, Röttgen P, Takada Y, Le Gall F, Knackmuss S, Bassler N, Büttner C, Little M, Bode C, Peter K. Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries. FASEB J. 2004 Nov; 18(14):1704-6. PMID: 15522915.
      View in: PubMed
    53. Takatsuki H, Komatsu S, Sano R, Takada Y, Tsuji T. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer Res. 2004 Sep 01; 64(17):6065-70. PMID: 15342388.
      View in: PubMed
    54. Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell. 2004 Oct; 15(10):4416-25. PMID: 15254262.
      View in: PubMed
    55. Majumdar M, Tarui T, Shi B, Akakura N, Ruf W, Takada Y. Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). J Biol Chem. 2004 Sep 03; 279(36):37528-34. PMID: 15247268.
      View in: PubMed
    56. Kamata T, Ambo H, Puzon-McLaughlin W, Tieu KK, Handa M, Ikeda Y, Takada Y. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J. 2004 Mar 15; 378(Pt 3):1079-82. PMID: 14690453.
      View in: PubMed
    57. Murata K, Miyoshi E, Ihara S, Noura S, Kameyama M, Ishikawa O, Doki Y, Yamada T, Ohigashi H, Sasaki Y, Higashiyama M, Tarui T, Takada Y, Kannagi R, Taniguchi N, Imaoka S. Attachment of human colon cancer cells to vascular endothelium is enhanced by N-acetylglucosaminyltransferase V. Oncology. 2004; 66(6):492-501. PMID: 15452379.
      View in: PubMed
    58. Graham KL, Halasz P, Tan Y, Hewish MJ, Takada Y, Mackow ER, Robinson MK, Coulson BS. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol. 2003 Sep; 77(18):9969-78. PMID: 12941907.
      View in: PubMed
    59. Londrigan SL, Graham KL, Takada Y, Halasz P, Coulson BS. Monkey rotavirus binding to alpha2beta1 integrin requires the alpha2 I domain and is facilitated by the homologous beta1 subunit. J Virol. 2003 Sep; 77(17):9486-501. PMID: 12915563.
      View in: PubMed
    60. Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, Kuo A, Loskutoff DJ, Cines DB, Takada Y. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem. 2003 Aug 08; 278(32):29863-72. PMID: 12754207.
      View in: PubMed
    61. Kariya Y, Tsubota Y, Hirosaki T, Mizushima H, Puzon-McLaughlin W, Takada Y, Miyazaki K. Differential regulation of cellular adhesion and migration by recombinant laminin-5 forms with partial deletion or mutation within the G3 domain of alpha3 chain. J Cell Biochem. 2003 Feb 15; 88(3):506-20. PMID: 12532327.
      View in: PubMed
    62. Tani N, Higashiyama S, Kawaguchi N, Madarame J, Ota I, Ito Y, Ohoka Y, Shiosaka S, Takada Y, Matsuura N. Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. Br J Cancer. 2003 Jan 27; 88(2):327-33. PMID: 12610521.
      View in: PubMed
    63. Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM. ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem. 2003 Mar 14; 278(11):9576-84. PMID: 12509413.
      View in: PubMed
    64. Lévesque JP, Takada Y, Puzon-McLaughlin W, Simmons PJ. A novel monoclonal antibody recognizing a cation-dependent epitope within the regulatory loop of human beta(1) integrin (CD29). Hybrid Hybridomics. 2002 Aug; 21(4):253-60. PMID: 12193278.
      View in: PubMed
    65. Legge GB, Morris GM, Sanner MF, Takada Y, Olson AJ, Grynszpan F. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity. Proteins. 2002 Aug 01; 48(2):151-60. PMID: 12112684.
      View in: PubMed
    66. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem. 2002 Sep 13; 277(37):33564-70. PMID: 12087108.
      View in: PubMed
    67. Miao H, Li S, Hu YL, Yuan S, Zhao Y, Chen BP, Puzon-McLaughlin W, Tarui T, Shyy JY, Takada Y, Usami S, Chien S. Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci. 2002 May 15; 115(Pt 10):2199-206. PMID: 11973360.
      View in: PubMed
    68. Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaughlin W, Zhang XP, Sheppard D, Engvall E, Takada Y. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem. 2002 May 17; 277(20):17804-10. PMID: 11882657.
      View in: PubMed
    69. Kamata T, Tieu KK, Tarui T, Puzon-McLaughlin W, Hogg N, Takada Y. The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1). J Immunol. 2002 Mar 01; 168(5):2296-301. PMID: 11859118.
      View in: PubMed
    70. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross J, Honjo T, Chien KR. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature. 2002 01 10; 415(6868):171-5. PMID: 11805835.
      View in: PubMed
    71. Kikkawa H, Kaihou M, Horaguchi N, Uchida T, Imafuku H, Takiguchi A, Yamazaki Y, Koike C, Kuruto R, Kakiuchi T, Tsukada H, Takada Y, Matsuura N, Oku N. Role of integrin alpha(v)beta3 in the early phase of liver metastasis: PET and IVM analyses. Clin Exp Metastasis. 2002; 19(8):717-25. PMID: 12553378.
      View in: PubMed
    72. Kamata T, Takada Y. Platelet integrin alphaIIbbeta3-ligand interactions: what can we learn from the structure? Int J Hematol. 2001 Dec; 74(4):382-9. PMID: 11794692.
      View in: PubMed
    73. Kamata T, Tieu KK, Irie A, Springer TA, Takada Y. Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller model. J Biol Chem. 2001 Nov 23; 276(47):44275-83. PMID: 11557768.
      View in: PubMed
    74. Tarui T, Miles LA, Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem. 2001 Oct 26; 276(43):39562-8. PMID: 11514539.
      View in: PubMed
    75. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001 Jun; 7(6):687-92. PMID: 11385505.
      View in: PubMed
    76. Tani N, Matsumoto K, Ota I, Yoshida S, Takada Y, Shiosaka S, Matsuura N. Effects of fibronectin cleaved by neuropsin on cell adhesion and migration. Neurosci Res. 2001 Feb; 39(2):247-51. PMID: 11223470.
      View in: PubMed
    77. Triantafilou K, Takada Y, Triantafilou M. Mechanisms of integrin-mediated virus attachment and internalization process. Crit Rev Immunol. 2001; 21(4):311-22. PMID: 11922076.
      View in: PubMed
    78. Eto K, Puzon-McLaughlin W, Sheppard D, Sehara-Fujisawa A, Zhang XP, Takada Y. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem. 2000 Nov 10; 275(45):34922-30. PMID: 10944520.
      View in: PubMed
    79. Tarui T, Mazar AP, Cines DB, Takada Y. Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem. 2001 Feb 09; 276(6):3983-90. PMID: 11053440.
      View in: PubMed
    80. Higgins JM, Cernadas M, Tan K, Irie A, Wang J, Takada Y, Brenner MB. The role of alpha and beta chains in ligand recognition by beta 7 integrins. J Biol Chem. 2000 Aug 18; 275(33):25652-64. PMID: 10837471.
      View in: PubMed
    81. Humphries JD, Askari JA, Zhang XP, Takada Y, Humphries MJ, Mould AP. Molecular basis of ligand recognition by integrin alpha5beta 1. II. Specificity of arg-gly-Asp binding is determined by Trp157 OF THE alpha subunit. J Biol Chem. 2000 Jul 07; 275(27):20337-45. PMID: 10764747.
      View in: PubMed
    82. Triantafilou K, Triantafilou M, Takada Y, Fernandez N. Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors. J Virol. 2000 Jul; 74(13):5856-62. PMID: 10846065.
      View in: PubMed
    83. Yokoyama K, Erickson HP, Ikeda Y, Takada Y. Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3. J Biol Chem. 2000 Jun 02; 275(22):16891-8. PMID: 10747940.
      View in: PubMed
    84. Triantafilou M, Triantafilou K, Wilson KM, Takada Y, Fernandez N. High affinity interactions of Coxsackievirus A9 with integrin alphavbeta3 (CD51/61) require the CYDMKTTC sequence of beta3, but do not require the RGD sequence of the CAV-9 VP1 protein. Hum Immunol. 2000 May; 61(5):453-9. PMID: 10773347.
      View in: PubMed
    85. Cal S, Freije JM, López JM, Takada Y, López-Otín C. ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism. Mol Biol Cell. 2000 Apr; 11(4):1457-69. PMID: 10749942.
      View in: PubMed
    86. Puzon-McLaughlin W, Kamata T, Takada Y. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem. 2000 Mar 17; 275(11):7795-802. PMID: 10713093.
      View in: PubMed
    87. Hewish MJ, Takada Y, Coulson BS. Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol. 2000 Jan; 74(1):228-36. PMID: 10590110.
      View in: PubMed
    88. Kamata T, Liddington RC, Takada Y. Interaction between collagen and the alpha(2) I-domain of integrin alpha(2)beta(1). Critical role of conserved residues in the metal ion-dependent adhesion site (MIDAS) region. J Biol Chem. 1999 Nov 05; 274(45):32108-11. PMID: 10542245.
      View in: PubMed
    89. Zhang XP, Puzon-McLaughlin W, Irie A, Kovach N, Prokopishyn NL, Laferté S, Takeuchi K, Tsuji T, Takada Y. Alpha 3 beta 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha 3 N-terminal repeats 2 and 3. Biochemistry. 1999 Oct 26; 38(43):14424-31. PMID: 10572017.
      View in: PubMed
    90. Triantafilou M, Triantafilou K, Wilson KM, Takada Y, Fernandez N, Stanway G. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J Gen Virol. 1999 Oct; 80 ( Pt 10):2591-600. PMID: 10573151.
      View in: PubMed
    91. Yokoyama K, Zhang XP, Medved L, Takada Y. Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains. Biochemistry. 1999 May 04; 38(18):5872-7. PMID: 10231539.
      View in: PubMed
    92. Meredith JE, Kiosses WB, Takada Y, Schwartz MA. Mutational analysis of cell cycle inhibition by integrin beta1C. J Biol Chem. 1999 Mar 19; 274(12):8111-6. PMID: 10075712.
      View in: PubMed
    93. Prokopishyn NL, Puzon-McLaughlin W, Takada Y, Laferté S. Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J Cell Biochem. 1999 Feb 01; 72(2):189-209. PMID: 10022502.
      View in: PubMed
    94. Lampe PD, Nguyen BP, Gil S, Usui M, Olerud J, Takada Y, Carter WG. Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol. 1998 Dec 14; 143(6):1735-47. PMID: 9852164.
      View in: PubMed
    95. Ambo H, Kamata T, Handa M, Taki M, Kuwajima M, Kawai Y, Oda A, Murata M, Takada Y, Watanabe K, Ikeda Y. Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients. Biochem Biophys Res Commun. 1998 Oct 29; 251(3):763-8. PMID: 9790984.
      View in: PubMed
    96. Akatsu T, Ono K, Murakami T, Katayama Y, Nishikawa M, Wada S, Yamamoto M, Kugai N, Matsuura N, Takada Y, Nagata N. Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro. J Bone Miner Res. 1998 Aug; 13(8):1251-9. PMID: 9718193.
      View in: PubMed
    97. Ambo H, Kamata T, Handa M, Kawai Y, Oda A, Murata M, Takada Y, Ikeda Y. Novel point mutations in the alphaIIb subunit (Phe289-->Ser, Glu324-->Lys and Gln747-->Pro) causing thrombasthenic phenotypes in four Japanese patients. Br J Haematol. 1998 Aug; 102(3):829-40. PMID: 9722314.
      View in: PubMed
    98. Tsuchida J, Ueki S, Takada Y, Saito Y, Takagi J. The 'ligand-induced conformational change' of alpha 5 beta 1 integrin. Relocation of alpha 5 subunit to uncover the beta 1 stalk region. J Cell Sci. 1998 Jun; 111 ( Pt 12):1759-66. PMID: 9601105.
      View in: PubMed
    99. Mould AP, Garratt AN, Puzon-McLaughlin W, Takada Y, Humphries MJ. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J. 1998 May 01; 331 ( Pt 3):821-8. PMID: 9560310.
      View in: PubMed
    100. Zhang XP, Kamata T, Yokoyama K, Puzon-McLaughlin W, Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3. J Biol Chem. 1998 Mar 27; 273(13):7345-50. PMID: 9516430.
      View in: PubMed
    101. King SL, Kamata T, Cunningham JA, Emsley J, Liddington RC, Takada Y, Bergelson JM. Echovirus 1 interaction with the human very late antigen-2 (integrin alpha2beta1) I domain. Identification of two independent virus contact sites distinct from the metal ion-dependent adhesion site. J Biol Chem. 1997 Nov 07; 272(45):28518-22. PMID: 9353313.
      View in: PubMed
    102. Takada Y, Kamata T, Irie A, Puzon-McLaughlin W, Zhang XP. Structural basis of integrin-mediated signal transduction. Matrix Biol. 1997 Oct; 16(4):143-51. PMID: 9402003.
      View in: PubMed
    103. Takagi J, Kamata T, Meredith J, Puzon-McLaughlin W, Takada Y. Changing ligand specificities of alphavbeta1 and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J Biol Chem. 1997 Aug 08; 272(32):19794-800. PMID: 9242639.
      View in: PubMed
    104. Mould AP, Askari JA, Aota Si, Yamada KM, Irie A, Takada Y, Mardon HJ, Humphries MJ. Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit. J Biol Chem. 1997 Jul 11; 272(28):17283-92. PMID: 9211865.
      View in: PubMed
    105. Irie A, Kamata T, Takada Y. Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1. Proc Natl Acad Sci U S A. 1997 Jul 08; 94(14):7198-203. PMID: 9207068.
      View in: PubMed
    106. Irie A, Kamata T, Takada Y. [Molecular mechanisms of integrin-ligand interaction]. Tanpakushitsu Kakusan Koso. 1997 Jul; 42(10 Suppl):1679-86. PMID: 9279099.
      View in: PubMed
    107. Takagi J, Isobe T, Takada Y, Saito Y. Structural interlock between ligand-binding site and stalk-like region of beta1 integrin revealed by a monoclonal antibody recognizing conformation-dependent epitope. J Biochem. 1997 May; 121(5):914-21. PMID: 9192733.
      View in: PubMed
    108. Isobe T, Hisaoka T, Shimizu A, Okuno M, Aimoto S, Takada Y, Saito Y, Takagi J. Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. J Biol Chem. 1997 Mar 28; 272(13):8447-53. PMID: 9079671.
      View in: PubMed
    109. Faull RJ, Wang J, Leavesley DI, Puzon W, Russ GR, Vestweber D, Takada Y. A novel activating anti-beta1 integrin monoclonal antibody binds to the cysteine-rich repeats in the beta1 chain. J Biol Chem. 1996 Oct 11; 271(41):25099-106. PMID: 8810264.
      View in: PubMed
    110. Irie A, Kamata T, Takada Y. [Integrin family]. Rinsho Byori. 1996 Sep; Suppl 102:16-23. PMID: 9128069.
      View in: PubMed
    111. Puzon-McLaughlin W, Takada Y. Critical residues for ligand binding in an I domain-like structure of the integrin beta1 subunit. J Biol Chem. 1996 Aug 23; 271(34):20438-43. PMID: 8702782.
      View in: PubMed
    112. Kamata T, Irie A, Tokuhira M, Takada Y. Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem. 1996 Aug 02; 271(31):18610-5. PMID: 8702512.
      View in: PubMed
    113. Puzon-McLaughlin W, Yednock TA, Takada Y. Regulation of conformation and ligand binding function of integrin alpha5beta1 by the beta1 cytoplasmic domain. J Biol Chem. 1996 Jul 12; 271(28):16580-5. PMID: 8663265.
      View in: PubMed
    114. Sechler JL, Takada Y, Schwarzbauer JE. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol. 1996 Jul; 134(2):573-83. PMID: 8707839.
      View in: PubMed
    115. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol. 1996 Jul; 70(7):4502-8. PMID: 8676475.
      View in: PubMed
    116. Luque A, Gómez M, Puzon W, Takada Y, Sánchez-Madrid F, Cabañas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem. 1996 May 10; 271(19):11067-75. PMID: 8626649.
      View in: PubMed
    117. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K, Takada Y. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol. 1996 Jan; 148(1):55-61. PMID: 8546226.
      View in: PubMed
    118. Irie A, Kamata T, Puzon-McLaughlin W, Takada Y. Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits. EMBO J. 1995 Nov 15; 14(22):5550-6. PMID: 8521812.
      View in: PubMed
    119. Meredith J, Takada Y, Fornaro M, Languino LR, Schwartz MA. Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C. Science. 1995 Sep 15; 269(5230):1570-2. PMID: 7545312.
      View in: PubMed
    120. Matsuura N, Tashita E, Yamamura J, Kagawa Y, Takada Y. [Analysis of the mechanism of tumor metastasis by the transfection of integrin cDNA]. Nihon Rinsho. 1995 Jul; 53(7):1643-7. PMID: 7630001.
      View in: PubMed
    121. Matsuura N, Takada Y. [Subclassification, molecular structure, function and ligand in integrin superfamily]. Nihon Rinsho. 1995 Jul; 53(7):1623-30. PMID: 7629999.
      View in: PubMed
    122. Kamata T, Wright R, Takada Y. Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem. 1995 May 26; 270(21):12531-5. PMID: 7539004.
      View in: PubMed
    123. Kamata T, Puzon W, Takada Y. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) Biochem J. 1995 Feb 01; 305 ( Pt 3):945-51. PMID: 7531439.
      View in: PubMed
    124. Kamata T, Takada Y. Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem. 1994 Oct 21; 269(42):26006-10. PMID: 7523399.
      View in: PubMed
    125. Kamata T, Puzon W, Takada Y. Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) J Biol Chem. 1994 Apr 01; 269(13):9659-63. PMID: 7511592.
      View in: PubMed
    126. Takada Y, Puzon W. Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J Biol Chem. 1993 Aug 15; 268(23):17597-601. PMID: 7688727.
      View in: PubMed
    127. Ylänne J, Chen Y, O'Toole TE, Loftus JC, Takada Y, Ginsberg MH. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J Cell Biol. 1993 Jul; 122(1):223-33. PMID: 8314843.
      View in: PubMed
    128. Weitzman JB, Pasqualini R, Takada Y, Hemler ME. The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem. 1993 Apr 25; 268(12):8651-7. PMID: 8473308.
      View in: PubMed
    129. Symington BE, Takada Y, Carter WG. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion. J Cell Biol. 1993 Jan; 120(2):523-35. PMID: 8421064.
      View in: PubMed
    130. Kawaguchi S, Kikuchi K, Ishii S, Takada Y, Kobayashi S, Uede T. VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Jpn J Cancer Res. 1992 Dec; 83(12):1304-16. PMID: 1282907.
      View in: PubMed
    131. Takada Y, Ylänne J, Mandelman D, Puzon W, Ginsberg MH. A point mutation of integrin beta 1 subunit blocks binding of alpha 5 beta 1 to fibronectin and invasin but not recruitment to adhesion plaques. J Cell Biol. 1992 Nov; 119(4):913-21. PMID: 1385446.
      View in: PubMed
    132. Minatogawa Y, Tone S, Allsop J, Purdue PE, Takada Y, Danpur CJ, Kido R. A serine-to-phenylalanine substitution leads to loss of alanine:glyoxylate aminotransferase catalytic activity and immunoreactivity in a patient with primary hyperoxaluria type 1. Hum Mol Genet. 1992 Nov; 1(8):643-4. PMID: 1301173.
      View in: PubMed
    133. Neuhaus H, Hu MC, Hemler ME, Takada Y, Holzmann B, Weissman IL. Cloning and expression of cDNAs for the alpha subunit of the murine lymphocyte-Peyer's patch adhesion molecule. J Cell Biol. 1991 Nov; 115(4):1149-58. PMID: 1840602.
      View in: PubMed
    134. Takada Y, Murphy E, Pil P, Chen C, Ginsberg MH, Hemler ME. Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J Cell Biol. 1991 Oct; 115(1):257-66. PMID: 1655803.
      View in: PubMed
    135. Chan BM, Matsuura N, Takada Y, Zetter BR, Hemler ME. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science. 1991 Mar 29; 251(5001):1600-2. PMID: 2011740.
      View in: PubMed
    136. Hemler ME, Elices MJ, Chan BM, Zetter B, Matsuura N, Takada Y. Multiple ligand binding functions for VLA-2 (alpha 2 beta 1) and VLA-3 (alpha 3 beta 1) in the integrin family. Cell Differ Dev. 1990 Dec 02; 32(3):229-38. PMID: 1965952.
      View in: PubMed
    137. Purdue PE, Takada Y, Danpure CJ. Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol. 1990 Dec; 111(6 Pt 1):2341-51. PMID: 1703535.
      View in: PubMed
    138. Takada Y, Kaneko N, Esumi H, Purdue PE, Danpure CJ. Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon. Biochem J. 1990 Jun 01; 268(2):517-20. PMID: 2363689.
      View in: PubMed
    139. Hemler ME, Elices MJ, Parker C, Takada Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev. 1990 Apr; 114:45-65. PMID: 2142475.
      View in: PubMed
    140. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 1990 Feb 23; 60(4):577-84. PMID: 1689216.
      View in: PubMed
    141. Takada Y, Hemler ME. The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol. 1989 Jul; 109(1):397-407. PMID: 2545729.
      View in: PubMed
    142. Takada Y, Elices MJ, Crouse C, Hemler ME. The primary structure of the alpha 4 subunit of VLA-4: homology to other integrins and a possible cell-cell adhesion function. EMBO J. 1989 May; 8(5):1361-8. PMID: 2788572.
      View in: PubMed
    143. Takada Y, Wayner EA, Carter WG, Hemler ME. Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA-2 and VLA-3 in the VLA family of heterodimers. J Cell Biochem. 1988 Aug; 37(4):385-93. PMID: 2458366.
      View in: PubMed
    144. Hemler ME, Crouse C, Takada Y, Sonnenberg A. Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures. J Biol Chem. 1988 Jun 05; 263(16):7660-5. PMID: 2967289.
      View in: PubMed
    145. Hemler ME, Huang C, Takada Y, Schwarz L, Strominger JL, Clabby ML. Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem. 1987 Aug 25; 262(24):11478-85. PMID: 3497921.
      View in: PubMed
    146. Takada Y, Strominger JL, Hemler ME. The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. Proc Natl Acad Sci U S A. 1987 May; 84(10):3239-43. PMID: 3033641.
      View in: PubMed
    147. Takada Y, Tsukiji N. Peroxisomal localization and activation by bivalent metal ions of ureidoglycolate lyase, the enzyme involved in urate degradation in Candida tropicalis. J Bacteriol. 1987 May; 169(5):2284-6. PMID: 3571167.
      View in: PubMed
    148. De Bruyn J, Huygen K, Bosmans R, Fauville M, Lippens R, Van Vooren JP, Falmagne P, Weckx M, Wiker HG, Harboe M. Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog. 1987 May; 2(5):351-66. PMID: 3148811.
      View in: PubMed
    149. Takada Y, Huang C, Hemler ME. Fibronectin receptor structures in the VLA family of heterodimers. Nature. 1987 Apr 9-15; 326(6113):607-9. PMID: 3031508.
      View in: PubMed
    150. Takada Y, Noguchi T. Aromatic-amino acid-glyoxylate aminotransferase from rat liver. Methods Enzymol. 1987; 142:273-9. PMID: 3037260.
      View in: PubMed
    151. Takada Y, Noguchi T. Ureidoglycollate lyase, a new metalloenzyme of peroxisomal urate degradation in marine fish liver. Biochem J. 1986 Apr 15; 235(2):391-7. PMID: 3741398.
      View in: PubMed
    152. Takada Y, Noguchi T. Characteristics of alanine: glyoxylate aminotransferase from Saccharomyces cerevisiae, a regulatory enzyme in the glyoxylate pathway of glycine and serine biosynthesis from tricarboxylic acid-cycle intermediates. Biochem J. 1985 Oct 01; 231(1):157-63. PMID: 3933486.
      View in: PubMed
    153. Takada Y, Mori T, Noguchi T. The effect of vitamin B6 deficiency on alanine: glyoxylate aminotransferase isoenzymes in rat liver. Arch Biochem Biophys. 1984 Feb 15; 229(1):1-6. PMID: 6703688.
      View in: PubMed
    154. Noguchi T, Fujiwara S, Takada Y, Mori T, Nagano M, Hanada N, Saeki E, Yasuo O. Enzymatic and immunological comparison of alanine: glyoxylate aminotransferases from different fish and mammalian livers. Comp Biochem Physiol B. 1984; 77(2):279-83. PMID: 6697688.
      View in: PubMed
    155. Takada Y, Noguchi T. The degradation of urate in liver peroxisomes. Association of allantoinase with allantoicase in amphibian liver but not in fish and invertebrate liver. J Biol Chem. 1983 Apr 25; 258(8):4762-4. PMID: 6833275.
      View in: PubMed
    156. Takada Y, Noguchi T, Okabe T, Kajiyama M. Superoxide dismutase in various tissues from rabbits bearing the Vx-2 carcinoma in the maxillary sinus. Cancer Res. 1982 Oct; 42(10):4233-5. PMID: 7105016.
      View in: PubMed
    157. Takada Y, Noguchi T. The evolution of peroxisomal and mitochondrial alanine: glyoxylate aminotransferase 1 in mammalian liver. Biochem Biophys Res Commun. 1982 Sep 16; 108(1):153-7. PMID: 6816225.
      View in: PubMed
    158. Noguchi T, Fujiwara S, Takada Y, Mori T, Nagano M. Metabolism of urea and glyoxylate, degradative products of purines in marine animals. J Biochem. 1982 Aug; 92(2):525-9. PMID: 7130155.
      View in: PubMed
    159. Takada Y, Noguchi T. Subcellular distribution, and physical and immunological properties of hepatic alanine: glyoxylate aminotransferase isoenzymes in different mammalian species. Comp Biochem Physiol B. 1982; 72(4):597-604. PMID: 7128113.
      View in: PubMed
    160. Takada Y, Noguchi T. Increase in hepatic pyruvate (glyoxylate) aminotransferase activity on administration of clofibrate to the rat. Biochem Pharmacol. 1981 Feb 15; 30(4):393-4. PMID: 7213428.
      View in: PubMed
    161. Noguchi T, Takada Y. The appearance of a new aromatic aminotransferase in the small intestines of vitamin B6-deficient rats. J Biol Chem. 1980 Oct 25; 255(20):9844-7. PMID: 7430106.
      View in: PubMed
    162. Noguchi T, Takada Y. Peroxisomal localization of alanine: glyoxylate aminotransferase in human liver. Arch Biochem Biophys. 1979 Sep; 196(2):645-7. PMID: 485171.
      View in: PubMed
    163. Noguchi T, Takada Y, Oota Y. Intraperoxisomal and intramitochondrial localization, and assay of pyruvate (glyoxylate) aminotransferase from rat liver. Hoppe Seylers Z Physiol Chem. 1979 Jul; 360(7):919-27. PMID: 114470.
      View in: PubMed
    164. Noguchi T, Takada Y, Fujiwara S. Degradation of uric acid to urea and glyoxylate in peroxisomes. J Biol Chem. 1979 Jun 25; 254(12):5272-5. PMID: 447647.
      View in: PubMed
    165. Noguchi T, Takada Y. Peroxisomal localization of serine:pyruvate aminotransferase in human liver. J Biol Chem. 1978 Nov 10; 253(21):7598-600. PMID: 701275.
      View in: PubMed
    166. Noguchi T, Takada Y. Purification and properties of peroxisomal pyruvate (glyoxylate) aminotransferase from rat liver. Biochem J. 1978 Nov 01; 175(2):765-8. PMID: 743224.
      View in: PubMed
    167. Noguchi T, Minatogawa Y, Takada Y, Okuno E, Kido R. Subcellular distribution of pyruvate (glyoxylate) aminotransferases in rat liver. Biochem J. 1978 Jan 15; 170(1):173-5. PMID: 564694.
      View in: PubMed
    168. Noguchi T, Okuno E, Takada Y, Minatogawa Y, Okai K, Kido R. Characteristics of hepatic alanine-glyoxylate aminotransferase in different mammalian species. Biochem J. 1978 Jan 01; 169(1):113-22. PMID: 629740.
      View in: PubMed
    169. Noguchi T, Takada Y, Kido R. Glutamate-glyoxylate aminotransferase in rat liver cytosol. Purification, properties and identity with alanine-2-oxoglutarate aminotransferase. Hoppe Seylers Z Physiol Chem. 1977 Dec; 358(12):1533-42. PMID: 590935.
      View in: PubMed
    170. Noguchi T, Takada Y, Kido R. Characteristics of hepatic serine-pyruvate aminotransferase in different mammalian species. Biochem J. 1977 Mar 01; 161(3):609-14. PMID: 851432.
      View in: PubMed
    171. Takada Y, Noguchi T, Kido R. Purification, characterization and identification of aromatic 2-oxo acid reductase. Life Sci. 1977 Feb 15; 20(4):609-16. PMID: 190515.
      View in: PubMed